Summary
- Current Price
- As of today, DSGN price is $10.99, up +8.60% on
- Current Price All-Time High
- DSGN price is currently -74.44% below its historical high of $43.00 set on
- Market Cap
- DSGN current market cap is $626M, up +134.41% over the past 365 days
- PE Ratio
- DSGN PE ratio is unknown
- Revenue
- DSGN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DSGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Design Therapeutics, Inc. |
| Ticker | NASDAQ: DSGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | designtx.com |
| Employees | 56 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.99 | |
| Price, 1D Change | +8.60% | |
| $626M | ||
| - | ||
| - | ||
| 1.07 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.22 | ||
| EPS, 1Y Change | -38.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.22 | ||
| EPS Estimate | N/A | -$1.40 |
| EPS Est. Change | N/A | -15.33% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $10.99 | |
| Price Target | - | $14.00 |
| Price Tgt. Change | - | +27.39% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.90 | -$0.88 | +2.63% | |
| -$1.30 | -$1.22 | +6.50% | |
| -$1.40 | N/A | -15.33% | |
| -$1.71 | N/A | -40.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.99 | |
| $7.04 | ||
| SMA 200 vs Price | -35.91% | |
| $10.04 | ||
| SMA 50 vs Price | -8.67% | |
| 1.07 | ||
| $0.62 | ||
| 61.51 | ||
| 57.65% | ||
| 81.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.22 | ||
| -$622.00K | ||
| - | ||
| -$79.47M | ||
| - | ||
| -$69.79M | ||
| - | ||
| -$78.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 17.14 | ||
| 17.14 | ||
| - | ||
| - | ||
| 24.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.95 | ||
| -5.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $212.50M | ||
| $219.85M | ||
| $226.75M | ||
| $223.78M | ||
| $14.25M | ||
| $13.06M | ||
| $1.54M | ||
| $890.00K | ||
| $2.31M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $69.79M | ||
| $78.85M | ||
| $622.00K | ||
| $0.00 | ||
| $622.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$54.36M | ||
| $22.91M | ||
| $25.74M | ||
| $193.00K | ||
| -$54.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| Oppenheimer | ||
| Leerink Partners | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| Wedbush | → | |
| RBC Capital | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with DSGN
FAQ
What is the ticker symbol for Design Therapeutics, Inc.?
The ticker symbol for Design Therapeutics, Inc. is NASDAQ:DSGN
Does Design Therapeutics, Inc. pay dividends?
No, Design Therapeutics, Inc. does not pay dividends
What sector is Design Therapeutics, Inc. in?
Design Therapeutics, Inc. is in the Healthcare sector
What industry is Design Therapeutics, Inc. in?
Design Therapeutics, Inc. is in the Biotechnology industry
What country is Design Therapeutics, Inc. based in?
Design Therapeutics, Inc. is headquartered in United States
When did Design Therapeutics, Inc. go public?
Design Therapeutics, Inc. initial public offering (IPO) was on March 29, 2021
Is Design Therapeutics, Inc. in the S&P 500?
No, Design Therapeutics, Inc. is not included in the S&P 500 index
Is Design Therapeutics, Inc. in the NASDAQ 100?
No, Design Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Design Therapeutics, Inc. in the Dow Jones?
No, Design Therapeutics, Inc. is not included in the Dow Jones index
When was Design Therapeutics, Inc. last earnings report?
Design Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does Design Therapeutics, Inc. report earnings?
The next expected earnings date for Design Therapeutics, Inc. is May 7, 2026
Data Sources & References
- DSGN Official Website www.designtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1807120/000119312526098491/0001193125-26-098491-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1807120/000119312526098491/0001193125-26-098491-index.htm
- DSGN Profile on Yahoo Finance finance.yahoo.com/quote/DSGN
- DSGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dsgn